Afimmune

Afimmune is a drug discovery and development company focusing on fibrotic conditions such as non-alcoholic steatohepatitis (NASH) and pulmonary disorders such as chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF). It workes on the inflammatory conditions of the human primary organs, including heart, liver, and lungs.